Therefore, we attempted to synthesize K-560-related compounds in order to assess their inhibitory activities against HDAC1, 2, 3, 8 (Class I) and 6 (Class II) and ameliorating effects on in vitro cerebral ischemia and also to examine their SAR. The gene discussed is HDAC1; the disease is brain ischemia.